Primary Health Properties Interim Results To End-June 2012
Edison | Sep 19, 2012 06:29AM ET
The interim results included 6% growth in rental income y-o-y, on the back of rent reviews that averaged 2.7% pa and acquisitions, but lower profit and EPS due to higher finance charges on new debt. The first seven months of 2012 have seen £175m of debt refinance, an £18m equity issue and a £75m retail bond issue in July. That puts c £130m of headroom in place to be used to fund acquisitions, with income surpluses increasing dividend cover. Our assumptions – c £60m pa of acquisitions this year, £50m pa in FY13 and 2.5% pa at rent reviews – push cover up to 74% in FY13 vs 67% this year. The group sees potential to scale up faster and close the gap in FY14. The pipeline of new assets – £49m currently in solicitors’ hands – on top of £16m so far this year, could see it beat our growth target. Acquisitions should be EPS accretive, as net initial yields being achieved are generally between 5.75% and 6.25% pa, ahead of incremental debt costs.
Interim results: Lower profit reflects debt margin increase
Rents were higher, in line with increased portfolio scale and reviews, but underlying interim profit fell to £4.4m (H111: £5.4m) due to higher average debt costs resulting from increased margins after recent debt refinancing. We estimate the average cost of debt at 5.1% pa currently (FY11: 5.02%) if all facilities were fully drawn, including the new £75m retail bond, although incremental debt is available at LIBOR plus 2.5%, currently below 4% pa all-inclusive. We have adjusted forecasts for this and ‘cash-drag’ as new funds await deployment. There is c £157m of undrawn debt and cash – £130m headroom for acquisitions net of a £27m loan maturity, with c £10m commitments to fund and £49m of assets in solicitors’ hands.
NHS reforms expected to drive demand for new assets
Recent NHS reforms seek to increase patient choice and shift budget responsibility towards GPs. The process is expected to move more patient services into local communities and devolve non-critical care and diagnostic activities from general hospitals, both of which will need an upgrade to existing primary care facilities. That should increase demand for the kind of modern, specialist premises funded by PHP.
Valuation: 5.3% dividend yield, 378p mid-year DCF
We see the yield as the key to the valuation, even though the dividend is uncovered. We anticipate another 0.5p pa dividend increase in FY13e, so prospective yields of 5.3% at the current share price this year, 5.5% next. Any shortfall will be met from cash/debt (reducing NAV/share) until cover is restored. Mid-year EPRA NAV/share was 314.9p (FY12: 318.7p), the manager’s DCF of future cash flows 378p/share.
Get The News You Want
To Read the Entire Report Please Click on the pdf File Below.
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.